Abiomed ABMD
$ 381.02
0.0%
Quarterly report 2022-Q3
added 11-03-2022
Abiomed Financial Statements 2011-2024 | ABMD
Annual Financial Statements Abiomed
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
16.2 M | 8.64 B | 12.5 B | 13.3 B | 5.63 B | 4.1 B | 2.57 B | 932 M | 722 M | 934 M | 646 M |
Shares |
45.1 K | 45.2 M | 44.9 M | 44.2 M | 43.2 M | 42.2 M | 40.6 M | 39.3 M | 39.1 M | 38.4 M | 37.2 M |
Historical Prices |
359 | 324 | 171 | 325 | 187 | 113 | 90.3 | 38.1 | 26.7 | 13.4 | 18.5 |
Net Income |
226 M | 203 M | 259 M | 112 M | 52.1 M | 38.1 M | 114 M | 7.35 M | 15 M | 1.5 M | -11.8 M |
Revenue |
848 M | 841 M | 769 M | 594 M | 445 M | 330 M | 230 M | 184 M | 158 M | 126 M | 101 M |
Cost of Revenue |
162 M | 151 M | 130 M | 98.6 M | 70.6 M | 50.4 M | - | - | - | - | - |
Gross Profit |
- | 690 M | 640 M | 495 M | 375 M | 279 M | 190 M | 146 M | 127 M | 102 M | 79.2 M |
Operating Income |
230 M | 249 M | 225 M | 157 M | 90.1 M | 65.1 M | 28.7 M | 8.36 M | 16.5 M | 1.52 M | -11.2 M |
Interest Expense |
58.7 M | 7.61 M | 30.4 M | -388 K | -349 K | 339 K | -97 K | 49 K | 326 K | 9 K | -143 K |
EBITDA |
254 M | 270 M | 239 M | 168 M | 96.3 M | 68.4 M | 31.4 M | 10.9 M | 16.7 M | 3 M | -9.79 M |
Operating Expenses |
456 M | 440 M | 415 M | 338 M | 285 M | 214 M | 162 M | 138 M | 110 M | 100 M | 90.4 M |
General and Administrative Expenses |
334 M | 342 M | 322 M | 263 M | 218 M | 164 M | 126 M | 107 M | 84.2 M | 71.7 M | 62.3 M |
All numbers in USD currency
Quarterly Income Statement Abiomed
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 45.4 M | 45.5 M | 45.5 M | 45.5 M | 45.4 M | 45.4 M | 45.3 M | 45.2 M | 45.2 M | 45.1 M | 45 M | 45.1 M | 45.1 M | 45.3 M | 45.2 M | 45 M | 45 M | 45 M | 44.4 M | 44.2 M | 44.1 M | 43.9 M | 43.7 M | 43.4 M | 43.1 M | 43 M | 42.6 M | 42.4 M | 42.1 M | 42 M | 41.3 M | 40.9 M | 40.5 M | 40.4 M | 39.9 M | 39.6 M | 39.2 M | 39 M | 38.6 M | 39.4 M | 39.3 M | 39.3 M | 39.3 M | 38.5 M | 38.2 M | 38.1 M | 37.7 M |
Net Income |
- | 106 M | 161 M | - | 45.8 M | 57 M | 30.4 M | -26.5 M | 61.9 M | 61.9 M | 62.2 M | 44.6 M | 69.2 M | 69.2 M | 13.1 M | 88.9 M | 44.9 M | 44.9 M | 50.1 M | 36.8 M | 13.4 M | 24.5 M | 37.4 M | 37.4 M | 15.4 M | 15.4 M | 8.88 M | 12.9 M | 10.6 M | 10.6 M | 7.74 M | 8.86 M | 12.7 M | 12.7 M | 3.84 M | -1.71 M | 4.39 M | 4.39 M | 1.06 M | -1.72 M | 2.68 M | 2.68 M | 5.47 M | 3.12 M | 2.92 M | 2.92 M | 601 K | -4.59 M |
Revenue |
- | 266 M | 543 M | - | 261 M | 248 M | 501 M | 241 M | 232 M | 232 M | 210 M | 165 M | 222 M | 222 M | 205 M | 208 M | 201 M | 201 M | 182 M | 174 M | 154 M | 133 M | 132 M | 125 M | 115 M | 115 M | 103 M | 103 M | 85.8 M | 85.8 M | 76.4 M | 73.4 M | 62 M | 62 M | 51.9 M | 48.8 M | 46.2 M | 46.2 M | 44.3 M | 42.7 M | 38.2 M | 38.2 M | 37.4 M | 38.8 M | 32.2 M | 32.2 M | 29.5 M | 27.4 M |
Cost of Revenue |
- | 48.9 M | 102 M | - | 47.6 M | 43.9 M | 89.1 M | 46.1 M | 41.1 M | 41.1 M | 38.7 M | 36 M | 40 M | 40 M | 34.9 M | 37.1 M | 34 M | 34 M | 29.8 M | 30.1 M | 25 M | 21.6 M | 21.9 M | 19.3 M | 19 M | 17.3 M | 15.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | 58 M | 124 M | - | 64.6 M | 60.4 M | 11.2 M | - | 71.4 M | 71.4 M | 61.3 M | 34.1 M | 70.3 M | 70.3 M | 60.2 M | 60.7 M | 62.4 M | 62.4 M | 50.3 M | - | 44.8 M | 31.7 M | 33.1 M | - | 25.4 M | 61.1 M | 35.7 M | - | 17.4 M | 45.3 M | 27.8 M | - | 13.7 M | 16.3 M | 4.18 M | - | 4.59 M | 4.68 M | 91 K | - | 2.92 M | 12.4 M | 9.49 M | - | 2.23 M | -1.42 M | -3.66 M | - |
Interest Expense |
- | 80.7 M | 84.5 M | - | -7.58 M | 6.84 M | 46.8 M | - | 7.94 M | 7.94 M | 9.76 M | 24.6 M | 23.7 M | 23.7 M | -45.8 M | 39.4 M | -20 K | -20 K | -158 K | - | -81 K | -23 K | 79 K | - | -34 K | -225 K | -191 K | - | -29 K | 111 K | 140 K | - | -10 K | -38 K | -39 K | - | 20 K | 5 K | -15 K | - | 324 K | 311 K | -13 K | - | 39 K | 24 K | -15 K | - |
EBITDA |
- | 64.3 M | 137 M | - | 64.6 M | 67 M | 25 M | - | 71.4 M | 88.6 M | 72.5 M | 39.5 M | 70.3 M | 84.7 M | 69.2 M | 65.1 M | 62.4 M | 72.3 M | 53.3 M | - | 44.8 M | 31.7 M | 35.5 M | - | 25.4 M | 65.6 M | 38.7 M | - | 17.4 M | 47.5 M | 28.5 M | - | 13.7 M | 18.1 M | 5.37 M | - | 4.59 M | 6.55 M | 1.41 M | - | 2.92 M | 14.5 M | 10.9 M | - | 2.6 M | 1.66 M | -1.53 M | - |
Operating Expenses |
- | - | - | - | - | - | - | 132 M | 119 M | 110 M | 94.8 M | 109 M | 111 M | 110 M | 110 M | 107 M | 104 M | 102 M | 102 M | 96.8 M | 84.3 M | 79.5 M | 77.5 M | 76.4 M | 70.3 M | 71.1 M | 66.7 M | 59.5 M | 55.6 M | 51.4 M | 47.5 M | 44.4 M | 38.5 M | 38.1 M | 40.7 M | 36.6 M | 32.1 M | 33.9 M | 35.3 M | 30.7 M | 27.2 M | 24.3 M | 27.8 M | 27.6 M | 23.7 M | 23.2 M | 25.9 M | - |
General and Administrative Expenses |
- | 117 M | 235 M | - | 108 M | 103 M | 206 M | - | 86.2 M | 86.2 M | 79.2 M | 68.4 M | 85.7 M | 85.7 M | 86 M | 86.1 M | 80.2 M | 80.2 M | 78.9 M | - | 66.6 M | 60.1 M | 60.6 M | - | 53.9 M | 158 M | 104 M | - | 41.9 M | 119 M | 77.2 M | - | 30.1 M | 91.2 M | 29.5 M | - | 24.4 M | 78.5 M | 54.2 M | - | 20.9 M | 60.3 M | 39.4 M | - | 17.2 M | 51.7 M | 34.5 M | - |
All numbers in USD currency